Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research – Diabetes and Obesity

Volume 4

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2467-9607 (Print)
ISSN: 2352-3220 (Online)
ISBN: 978-1-68108-446-6 (Print)
ISBN: 978-1-68108-445-9 (Online)
Year of Publication: 2019
DOI: 10.2174/97816810844591170401

Introduction

Frontiers in Clinical Drug Research – Diabetes and Obesity is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.

The fourth volume of this series features 7 chapters:

  • -Pharmacologic Obesity Treatment
  • -Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications
  • -Sodium–Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus
  • -The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy
  • -Through the Perspective of Histology – The Alzheimer’s Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes
  • -Pharmacological Mechanism of PPARγ Ratio in Diabetes and Obesity
  • -Hydrogen Sulfide and Carbohydrate Metabolism

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii-iii (2)
Atta-ur-Rahman
Download Free

Pharmacologic Obesity Treatment – Emphasis on Efficacy and Cardiometabolic Markers

- Pp. 1-19 (19)
Fariha Salman, Ivan Gerling, Helmut O. Steinberg
View Abstract

Interplay Between Bile Acid and GLP-1 Receptor Agonist Signaling Informs the Design of Drugs to Combat Obesity and its Metabolic Complications

- Pp. 20-57 (38)
Jessica Felton, Jean-Pierre Raufman
View Abstract

Sodium–Glucose Co-Transporters Inhibitors for Type 2 Diabetes Mellitus: The ‘New Kids on the Block’ in the Era of Evidence-based Medicine

- Pp. 58-107 (50)
Cheow Peng Ooi, Norlaila Mustafa, Nor Azmi Kamaruddin, Munn Sann Lye
View Abstract

The Effects of Traditional Chinese Medicine on Inflammatory Cytokines in Diabetic Nephropathy: The Progress in the Past Decades

- Pp. 108-134 (27)
Xiang Tu, Yuan Ping Deng, Ming Chen, James B. Jordan, Sen Zhong
View Abstract

Through the Perspective of Histology - The Alzheimer’s Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes

- Pp. 135-198 (64)
Cigdem Elmas, Cemile Merve Seymen
View Abstract

Pharmacological Mechanism of PPARγ Ratio in Diabetes and Obesity

- Pp. 199-225 (27)
Jose Roberto Santin, Marina Jagielski Goss, Nara Lins Meira Quintao
View Abstract

Hydrogen Sulfide and Carbohydrate Metabolism

- Pp. 226-258 (33)
Zahra Bahadoran, Parvin Mirmiran, Asghar Ghasemi
View Abstract

Subject Index

- Pp. 259-266 (8)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Diabesity: A Multidisciplinary Approach.
.Pharmacological and Molecular Perspectives on Diabetes.
.Frontiers in Clinical Drug Research – Diabetes and Obesity.
.Phytotherapy in the Management of Diabetes and Hypertension.